Skip to main content

Nanoviricides, Inc.

NNVC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001379006

No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Nanoviricides, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of NNVC: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders43148+6
Shares3.11M605.6K1.90M−600.9K (−24.0%)
Value$3.51M$684.3K$1.73M−$1.09M (−38.7%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Nanoviricides, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to NNVC in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC511,477$466.5K0.00%
Vanguard Fiduciary Trust Co90,060$82.1K0.00%
Squarepoint Ops LLC58,138$53.0K0.00%
Virtu Financial LLC12,160$11.0K0.00%
Sandy Cove Advisors, LLC10,000$9.12K0.00%
Vanguard Global Advisers, LLC3,712$3.38K0.00%
Farther Finance Advisors, LLC500$4770.00%
Sound Income Strategies, LLC300$2860.00%
SBI Securities Co., Ltd.150$1370.00%
FMR LLC112$1020.00%
Cheviot Value Management, LLC72$660.00%
Harbour Investments, Inc.35$320.00%
Smartleaf Asset Management LLC14$120.00%
Caitong International Asset Management Co., Ltd1$10.00%

Sold out (8)

Institutions that held Nanoviricides, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of NNVC in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Armistice Capital, LLC1,368,000$1.55M
Citadel Advisors LLC79,915$90.3K
Two Sigma Securities, LLC17,211$19.4K
Simplex Trading, LLC2,803$3.17K
Bank of America Corp269$304
DecisionPoint Financial, LLC50$57
Northwestern Mutual Wealth Management Co35$40
Citigroup Inc1$1

Not filed for Q1 2026 yet (1)

Institutions that held Nanoviricides, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NNVC in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc605,583$684.3K